TC BioPharm (Holdings) PLC (TCBP)
1.50
+0.07
(+4.90%)
USD |
NASDAQ |
May 01, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Price to Book Value: 1.401 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 1.336 |
| April 29, 2024 | 1.392 |
| April 26, 2024 | 1.429 |
| April 25, 2024 | 1.466 |
| April 24, 2024 | 1.373 |
| April 23, 2024 | 1.476 |
| April 22, 2024 | 1.476 |
| April 19, 2024 | 1.382 |
| April 18, 2024 | 1.326 |
| April 17, 2024 | 1.261 |
| April 16, 2024 | 1.242 |
| April 15, 2024 | 1.224 |
| April 12, 2024 | 1.504 |
| April 11, 2024 | 1.616 |
| April 10, 2024 | 1.588 |
| April 09, 2024 | 1.737 |
| April 08, 2024 | 1.663 |
| April 05, 2024 | 1.775 |
| April 04, 2024 | 1.821 |
| April 03, 2024 | 1.214 |
| April 02, 2024 | 1.186 |
| April 01, 2024 | 1.186 |
| March 28, 2024 | 0.9293 |
| March 27, 2024 | 1.014 |
| March 26, 2024 | 1.007 |
| Date | Value |
|---|---|
| March 25, 2024 | 1.022 |
| March 22, 2024 | 1.078 |
| March 21, 2024 | 1.149 |
| March 20, 2024 | 1.092 |
| March 19, 2024 | 1.036 |
| March 18, 2024 | 1.149 |
| March 15, 2024 | 1.192 |
| March 14, 2024 | 1.362 |
| March 13, 2024 | 1.206 |
| March 12, 2024 | 1.277 |
| March 11, 2024 | 1.213 |
| March 08, 2024 | 0.7519 |
| March 07, 2024 | 0.7377 |
| March 06, 2024 | 0.7448 |
| March 05, 2024 | 0.8938 |
| March 04, 2024 | 0.8938 |
| March 01, 2024 | 0.9434 |
| February 29, 2024 | 0.8938 |
| February 28, 2024 | 0.9541 |
| February 27, 2024 | 0.9009 |
| February 26, 2024 | 0.8583 |
| February 23, 2024 | 0.7448 |
| February 22, 2024 | 0.8654 |
| February 21, 2024 | 0.7731 |
| February 20, 2024 | 0.8229 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2661
Minimum
Feb 05 2024
32.41
Maximum
Feb 17 2023
6.356
Average
3.029
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.527 |
| Biodexa Pharmaceuticals Plc | 0.9860 |
| NuCana PLC | 0.4292 |
| Autolus Therapeutics PLC | 9.554 |
| Mereo BioPharma Group PLC | 8.757 |
Price to Book Value Related Metrics
| PS Ratio | 0.1007 |
| Price | 1.50 |
| Earnings Yield | -337.1% |
| Market Cap | 4.793M |